ENOTTA Publications
- Tachkov, K., Nikolova, P., Vitanska-Simeonova, R., Boyadzhieva, V., Stoilov, N., & Petrova, G. (2023). Cost-effectiveness of therapeutic drug monitoring (TDM) of biologic treatment in rheumatic diseases: a narrative review. Biotechnology & Biotechnological Equipment, 37(1), 2250469. (Link)
- Skrede S, Bogavac-Stanojević N, Dreesen E, Nielsen E, Zaninotto M, Mulleman D. Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across Europe. Basic Clin Pharmacol Toxicol. 2024 Apr;134(4):556-560. doi: 10.1111/bcpt.13983. Epub 2024 Jan 26. PMID: 38278525. (Link)
- Petrova, G., Blagova, S., Tachkov, K., Santos, M., Bluett, J., Rumano, M., … & Mulleman, D. (2025). Therapeutic drug monitoring education: The current state. British Journal of Clinical Pharmacology. (Link)
- Eylenbosch A, Wei R, Soenen R, Smith C, Standing JF, Mahil S, Lambert J. From reactive to predictive: Advancing biologic dosing in dermatology. J Eur Acad Dermatol Venereol. 2025 Nov 14. doi: 10.1111/jdv.70147. Epub ahead of print. PMID: 41235748. (Link)
- Bluett J, Rumano M, Martínez Becerra MJ, Loeff F, Itik M, Ternant D, Desvignes C, Mulleman D, Skrede S. Quality Assessment of Therapeutic Drug Monitoring Assays of Therapeutic Antibodies Across Europe: An Update. Basic Clin Pharmacol Toxicol. 2025 Nov;137(5):e70129. doi: 10.1111/bcpt.70129. PMID: 41048129; PMCID: PMC12498310. (Link)
